-
EFFICACY EVALUATION
- CARDIOVASCULAR SYSTEM DISEASE
- CENTRAL NERVOUS SYSTEM DISEASE
- DERMATOLOGY
- GASTRO-INTESTINAL DISEASE
- INFLAMMATORY DISEASE
- LIVER & HEPATIC SYSTEM, Kidney
- Oncology
- OBESITY & METABOLIC DISORDERS DISEASE
- PAIN DISEASE
- PHARMACOKINETICS
- RESPIRATORY SYSTEM
- THROMBOSIS
- UROGENITAL SYSTEM
- Ophthalmology
- FIBROSIS
- Hearing Loss
- Safety Assessment
- Pathology Services
- Bio-Analytical Services
DART (Developmental and Reproductive Toxicology) Service
- Male/female fertility (Segment I)
- Embryo fetal (prenatal) developmental toxicity (Segment II )
- Pre and postnatal development (PPND) [Segment III] studies
- Reproduction/developmental toxicity screening test (OECD 421)
- Combined repeated dose toxicity study with the reproduction/developmental toxicity screening test (OECD 422)
- Two generation reproduction study (OECD 416)
- Extended one-generation reproductive toxicity study (OECD 443)
- Uterotrophic bioassay in Rodents (OECD 440)
- Hershberger bioassay in Rodents (OECD 441)
- Juvenile toxicity study
